Jeroen D C Codée Selected Research

Aziridines (Ethyleneimines)

5/2016

Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease Using In-Class, Broad-Spectrum Activity-Based Probes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeroen D C Codée Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 08/2017
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
3	Gaucher Disease (Gaucher's Disease) 01/2019 - 11/2014
3	Fabry Disease (Fabry's Disease) 08/2016 - 03/2013
2	Infections 04/2021 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 08/2014 - 08/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Leprosy (Hansen's Disease) 01/2021
1	Poisoning 01/2021
1	Communicable Diseases (Infectious Diseases) 12/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Mannosidase Deficiency Diseases (Mannosidosis) 01/2020
1	Streptococcal Infections (Streptococcal Infection) 08/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Mucopolysaccharidoses 12/2018
1	Mucopolysaccharidosis VII (Sly Syndrome) 08/2017
1	Inflammation (Inflammations) 08/2017
1	Gram-Positive Bacterial Infections 03/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 05/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2015
1	Fucosidosis 05/2015
1	Persistent Infection 08/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2013
1	Pneumonia (Pneumonitis) 03/2011

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 10/2021 - 12/2015
4	Polysaccharides (Glycans)IBA 04/2021 - 03/2011
3	GlucosidasesIBA 01/2019 - 05/2016
3	AlginatesIBA 08/2014 - 08/2013
2	AntibodiesIBA 04/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
2	GlycolipidsIBA 01/2021 - 12/2015
2	AnthracyclinesIBA 01/2021 - 11/2020
2	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021 - 03/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2020
2	VaccinesIBA 12/2020 - 03/2017
2	Conjugate VaccinesIBA 10/2020 - 01/2019
2	LigandsIBA 10/2020 - 01/2019
2	AntigensIBA 01/2020 - 01/2019
2	cyclophellitolIBA 01/2019 - 05/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Starch (Cornstarch)IBA 10/2021
1	Amylases FDA Link 10/2021
1	Histones (Histone)IBA 01/2021
1	TrisaccharidesIBA 01/2021
1	ChromatinIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	GlycoconjugatesIBA 12/2020
1	AclarubicinIBA 11/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidaseIBA 01/2020
1	conduritol epoxideIBA 01/2019
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2019
1	MannosidesIBA 01/2019
1	Toll-Like Receptor 7IBA 01/2019
1	cyclohexeneIBA 12/2018
1	Iduronidase (alpha-L-Iduronidase)IBA 12/2018
1	heparanaseIBA 08/2017
1	GlucuronidaseIBA 08/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 08/2016
1	4-nitrophenyl-alpha-glucosidaseIBA 05/2016
1	GlycogenIBA 05/2016
1	Aziridines (Ethyleneimines)IBA 05/2016
1	AcidsIBA 05/2016
1	Glucosylceramides (Glucocerebrosides)IBA 12/2015
1	alpha-L-Fucosidase (Fucosidase)IBA 05/2015
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2014
1	Hexosaminidases (Hexosaminidase)IBA 11/2014
1	GalactosidasesIBA 08/2014
1	HydrolasesIBA 08/2014
1	PolymersIBA 08/2013
1	globotriaosyl lysosphingolipidIBA 03/2013
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	SolventsIBA 03/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020
1	Immunotherapy 01/2021
1	Enzyme Replacement Therapy 03/2013